NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Recordati (BIT: REC)

 
REC Technical Analysis
5
As on 1st Nov 2017 REC Share Price closed @ 40.18 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 33.40 & Strong Buy for SHORT-TERM with Stoploss of 38.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

REC Share Price

Open 40.09 Change Price %
High 40.45 1 Day 0.27 0.68
Low 39.93 1 Week 0.00 0.00
Close 40.18 1 Month 0.44 1.11
Volume 169800 1 Year 14.08 53.95
52 Week High 40.52 | 52 Week Low 24.59
 
BIT Italy Most Active Stocks
RN 0.04 0.00%
PMI 0.36 0.00%
TIT 0.75 1.35%
ISP 2.89 0.00%
F 6.94 -2.12%
TIS 0.04 0.00%
SPM 3.80 5.26%
ENEL 5.39 1.32%
TITR 0.62 1.64%
CRG 0.21 0.00%
 
BIT Italy Top Gainers Stocks
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
AE 0.50 8.70%
AE 0.50 8.70%
DIS 0.28 7.69%
DIS 0.28 7.69%
DIS 0.28 7.69%
DIS 0.28 7.69%
 
BIT Italy Top Losers Stocks
ME 0.09 -10.00%
ME 0.09 -10.00%
FTL 3.65 -7.36%
TBS 1.64 -6.82%
STEF 0.19 -5.00%
POPR 0.59 -4.84%
BIM 0.65 -4.41%
BIM 0.65 -4.41%
ZUCR 0.24 -4.00%
S24 1.70 -3.95%
 
 
REC
Daily Charts
REC
Intraday Charts
Whats New @
Bazaartrend
REC
Free Analysis
 
REC Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE40.66
RESISTANCE40.46
SUPPORT39.90
SUPPORT39.70
SUPPORT0.00
SUPPORT0.00
 
REC Target for Month October
4th UP TARGET43.72
3rd UP TARGET42.49
2nd UP TARGET41.73
1st UP TARGET40.97
1st DOWN TARGET38.81
2nd DOWN TARGET38.05
3rd DOWN TARGET37.29
4th DOWN TARGET36.06
 
REC Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
REC Target for Year 2020
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
REC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website >
 
REC Address
REC
Via Matteo Civitali 1
Milano, MI 20148
Italy
Phone: 39 02 487871
Fax: 39 02 40 07 37 47
 
REC Latest News
 
Your Comments and Response on Recordati
 
REC Business Profile
Recordati S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals. It offers pharmaceuticals in various therapeutic areas, including antibiotics and antivirals, cardiovascular, central nervous system, dermatological, gastroenterology, genito-urinary system, muscolo-skeletal disorders and pain therapy, and obstetics and gynaecology; and non-prescription pharmaceuticals. The company’s flagship product is ZANIDIP (lercanidipine), a calcium-channel blocker for the treatment of hypertension. Its products also include Zanipress/Zanitek, a combination of lercanidipine and enalapril for the treatment of hypertension; Carbaglu, which is approved in the European Union and is under Phase III clinical trials in the United States for the treatment of organic acidemias; REC 0482 for the treatment of benign prostatic hyperplasia, which is under Phase III clinical trials; and Lercanidipine/enalapril fixed combination, which is in pre-registration stage for the treatment of essential hypertension. In addition, it offers gastroenterological drugs, oral rehydration products, probiotics, and OTC brands for gynecological use. Its products under Phase II clinical trials include Cystadrops for the treatment of ocular cystinosis, and REC 0422 to treat overactive bladder and incontinence; and Phase I clinical trials comprise REC 1819 for the treatment of overactive bladder and incontinence, and REC 0438 to treat overactive bladder in patients with spinal lesions. Further, the company produces pharmaceutical chemicals, such as active ingredients and intermediates for the generic drugs market. Recordati S.p.A has operations in Europe, Australasia, Africa, and the United States. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati S.p.A. is a subsidiary of Fimei S.p.A.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service